PARTEMPO
Glaxo Group Limited
| Research |
OneLook
Acronym Finder
|
| Serial Number | 78255721 |
| Registration Number | 2904832 |
| Mark Drawing Code | 1000: Typeset: Word(s)/letter(s)/number(s) |
| Cancellation Code | 2 |
| Domestic Representative | Maribeth Day Case |
| Attorney Name | Maribeth Day Case |
| Law Office Assigned | L80 |
| Employee Name | BUTLER, MIDGE FAE |
Timeline
| 2003-05-29 | Application Filed |
| 2004-08-31 | Published for Opposition |
| 2004-11-23 | Location: PUBLICATION AND ISSUE SECTION |
| 2004-11-23 | Trademark Registered |
| 2011-06-24 | Cancelled |
| 2011-06-24 | Status: Dead/Cancelled |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Glaxo Group Limited |
| Address | Glaxo Wellcome House Berkeley Avenue Greenford Middlesex GB UB6 0NN |
| Legal Entity Type | Corporation |
| Legal Entity State | GB |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, sepsis, alopecia and obesity and for the treatment of metabolic musculoskeletal cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and skin and tissue repair preparations |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| ASSIGNED TO EXAMINER | 2003-11-05 | 1 DOCK D:Assigned to Examiner |
| LETTER OF SUSPENSION E-MAILED | 2003-11-05 | 2 GNSL F:First Action |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2004-05-07 | 3 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2004-05-07 | 4 CRFA I:Incoming Correspondence |
| Sec. 1(B) CLAIM DELETED | 2004-05-07 | 5 1.BD I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2004-06-08 | 6 CNSA O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2004-08-11 | 7 NPUB O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2004-08-31 | 8 PUBO A:Allowance for Publication |
| REGISTERED-PRINCIPAL REGISTER | 2004-11-23 | 9 R.PR A:Allowance for Publication |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2010-05-13 | 10 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2010-05-13 | 11 ARAA I:Incoming Correspondence |
| CANCELLED SEC. 8 (6-YR) | 2011-06-24 | 12 C8.. O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 PARTEMPO 78325306 3026557 Dead/Cancelled |
Glaxo Group Limited 2003-11-10 |
 PARTEMPO 78255721 2904832 Dead/Cancelled |
Glaxo Group Limited 2003-05-29 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 